2014
Overview
Hypertension has long been identified as one of the most important risk factors for cardiovascular disease, and its impact on the cardiovascular system has been extensively studied by cardiology experts. Hypertension is a condition in which there is an increase in blood pressure, which can put excessive strain on the heart, causing it to work harder to pump blood throughout the body. It is estimated that about 1 billion people worldwide suffer from hypertension, and the number is expected to continue to rise in the coming years. One of the best ways to assess the impact of hypertension on the cardiovascular system is through the measurement of cerebral blood flow. This approach involves the use of advanced neuroimaging techniques such as magnetic resonance imaging (MRI) or positron emission tomography (PET), which can be used to measure blood flow to the brain. This test is known as a cerebral blood flow assay. Through cerebral blood flow assay, cardiology experts can observe changes in cerebral blood flow that are associated with hypertension. Specifically, reduced cerebral blood flow often indicates vascular damage that is caused by hypertension. The use of this test enables cardiology specialists to monitor patients and assess their risk of cardiovascular disease more accurately. In summary, cerebral blood flow assay is a cutting-edge scientific technology aimed at helping cardiology experts measure the impact of hypertension on the cardiovascular system. This technique is essential in assessing the risk of cardiovascular disease among hypertensive patients and also in monitoring the effectiveness of medications for hypertension.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.